Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Carlos Ramos Ramos

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|December 28, 2014
Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosisJosé Ramón Paño Pardo, Sergio Serrano Villar, Juan Carlos Ramos Ramos, et al.
Diagnostic Microbiology and Infectious Disease|August 6, 2021
Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: Surfing the first waveMario Ruiz-Bastián, Iker Falces-Romero, Juan Carlos Ramos-Ramos, et al.
Access Microbiology|January 13, 2022
Characteristics of patients with suspected COVID-19 pneumonia and repeatedly negative RT-PCRPaula Navarro-Carrera, Patricia Roces-Álvarez, Juan Carlos Ramos-Ramos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 8, 2020
Intestinal loads of OXA-48-producing Klebsiella pneumoniae in colonized patients determined from surveillance rectal swabsFernando Lázaro-Perona, María Rodríguez-Tejedor, Guillermo Ruiz-Carrascoso, et al.
Anaerobe|December 18, 2018
MALDI-TOF MS for rapid diagnosis of Anaerobiospirillum succiniciproducens, an unusual causative agent of bacteraemia in humans. Two case reports and literature reviewMarina Alguacil-Guillen, Luis Ramos-Ruperto, Juan Carlos Ramos Ramos, et al.
Antibiotics (Basel, Switzerland)|August 29, 2024
Challenges Facing Two Outbreaks of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant MutantsMontserrat Rodríguez-Aguirregabiria, Fernando Lázaro-Perona, Juana Begoña Cacho-Calvo, et al.
Gut Pathogens|April 14, 2020
Proof-of-concept trial of the combination of lactitol with <i>Bifidobacterium bifidum</i> and <i>Lactobacillus acidophilus</i> for the eradication of intestinal OXA-48-producing <i>Enterobacteriaceae</i>Juan Carlos Ramos-Ramos, Fernando Lázaro-Perona, José Ramón Arribas, et al.
Antimicrobial Resistance and Infection Control|October 22, 2025
Genomic analysis of carbapenem resistant Acinetobacter baumannii outbreak in a burn intensive care unit of a tertiary-care hospital in Madrid, SpainAlfredo Maldonado-Barrueco, Eduardo Rubio-Mora, Iván Bloise, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2016
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant OrganismsElizabeth Temkin, Julian Torre-Cisneros, Bojana Beovic, et al.
Research and Practice in Thrombosis and Haemostasis|January 23, 2023
No changes in hemostasis after COVID-19-heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS studyNora V Butta, Elena G Arias-Salgado, Elena Monzón Manzano, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Enfermedades Infecciosas Y Microbiologia Clinica|December 28, 2014
Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosisJosé Ramón Paño Pardo, Sergio Serrano Villar, Juan Carlos Ramos Ramos, et al.
Diagnostic Microbiology and Infectious Disease|August 6, 2021
Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: Surfing the first waveMario Ruiz-Bastián, Iker Falces-Romero, Juan Carlos Ramos-Ramos, et al.
Access Microbiology|January 13, 2022
Characteristics of patients with suspected COVID-19 pneumonia and repeatedly negative RT-PCRPaula Navarro-Carrera, Patricia Roces-Álvarez, Juan Carlos Ramos-Ramos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 8, 2020
Intestinal loads of OXA-48-producing Klebsiella pneumoniae in colonized patients determined from surveillance rectal swabsFernando Lázaro-Perona, María Rodríguez-Tejedor, Guillermo Ruiz-Carrascoso, et al.
Anaerobe|December 18, 2018
MALDI-TOF MS for rapid diagnosis of Anaerobiospirillum succiniciproducens, an unusual causative agent of bacteraemia in humans. Two case reports and literature reviewMarina Alguacil-Guillen, Luis Ramos-Ruperto, Juan Carlos Ramos Ramos, et al.
Antibiotics (Basel, Switzerland)|August 29, 2024
Challenges Facing Two Outbreaks of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant MutantsMontserrat Rodríguez-Aguirregabiria, Fernando Lázaro-Perona, Juana Begoña Cacho-Calvo, et al.
Gut Pathogens|April 14, 2020
Proof-of-concept trial of the combination of lactitol with <i>Bifidobacterium bifidum</i> and <i>Lactobacillus acidophilus</i> for the eradication of intestinal OXA-48-producing <i>Enterobacteriaceae</i>Juan Carlos Ramos-Ramos, Fernando Lázaro-Perona, José Ramón Arribas, et al.
Antimicrobial Resistance and Infection Control|October 22, 2025
Genomic analysis of carbapenem resistant Acinetobacter baumannii outbreak in a burn intensive care unit of a tertiary-care hospital in Madrid, SpainAlfredo Maldonado-Barrueco, Eduardo Rubio-Mora, Iván Bloise, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2016
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant OrganismsElizabeth Temkin, Julian Torre-Cisneros, Bojana Beovic, et al.
Research and Practice in Thrombosis and Haemostasis|January 23, 2023
No changes in hemostasis after COVID-19-heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS studyNora V Butta, Elena G Arias-Salgado, Elena Monzón Manzano, et al.
Pageof 2